  Although hyperthyroidism is a common disease, the pharmaceutical therapy is
based on a trial-and-error approach. We extend a mathematical model of the
pituitary-thyroid feedback loop such that the intake of one antithyroid agent,
namely methimazole (MMI), can be considered and use a model predictive control
(MPC) scheme to determine suitable dosages.
